Glennie MJ - Search Results

1

Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation.

Beers SA, Chan CH, James S, French RR, Attfield KE, Brennan CM, Ahuja A, Shlomchik MJ, Cragg MS, Glennie MJ. Beers SA, et al. Among authors: glennie mj. Blood. 2008 Nov 15;112(10):4170-7. doi: 10.1182/blood-2008-04-149161. Epub 2008 Jun 26. Blood. 2008. PMID: 18583569 Free PMC article.

2

Initial experience in treating human lymphoma with a combination of bispecific antibody and saporin.

Bonardi MA, Bell A, French RR, Gromo G, Hamblin T, Modena D, Tutt AL, Glennie MJ. Bonardi MA, et al. Among authors: glennie mj. Int J Cancer Suppl. 1992;7:73-7. Int J Cancer Suppl. 1992. PMID: 1428411

3

Characterization of a new monoclonal anti-Fc gamma RII antibody, AT10, and its incorporation into a bispecific F(ab')2 derivative for recruitment of cytotoxic effectors.

Greenman J, Tutt AL, George AJ, Pulford KA, Stevenson GT, Glennie MJ. Greenman J, et al. Among authors: glennie mj. Mol Immunol. 1991 Nov;28(11):1243-54. doi: 10.1016/0161-5890(91)90011-8. Mol Immunol. 1991. PMID: 1835758

4

Cooperative mixtures of bispecific F(ab')2 antibodies for delivering saporin to lymphoma in vitro and in vivo.

French RR, Courtenay AE, Ingamells S, Stevenson GT, Glennie MJ. French RR, et al. Among authors: glennie mj. Cancer Res. 1991 May 1;51(9):2353-61. Cancer Res. 1991. PMID: 2015599

5

Lymphokine-activated killer cells from normal and lymphoma subjects are cytotoxic for cells coated with antibody derivatives displaying human Fc gamma.

Dearman RJ, Stevenson FK, Wrightham M, Hamblin TJ, Glennie MJ, Stevenson GT. Dearman RJ, et al. Among authors: glennie mj. Blood. 1988 Dec;72(6):1985-91. Blood. 1988. PMID: 2973819 Free article.

6

Treatment of B-cell lymphomas with combination of bispecific antibodies and saporin.

French RR, Hamblin TJ, Bell AJ, Tutt AL, Glennie MJ. French RR, et al. Among authors: glennie mj. Lancet. 1995 Jul 22;346(8969):223-4. doi: 10.1016/s0140-6736(95)91271-1. Lancet. 1995. PMID: 7542357

7

Measurement of kinetic binding constants of a panel of anti-saporin antibodies using a resonant mirror biosensor.

George AJ, French RR, Glennie MJ. George AJ, et al. Among authors: glennie mj. J Immunol Methods. 1995 Jun 14;183(1):51-63. doi: 10.1016/0022-1759(95)00031-5. J Immunol Methods. 1995. PMID: 7602139

8

Delivery of saporin to human B-cell lymphoma using bispecific antibody: targeting via CD22 but not CD19, CD37, or immunoglobulin results in efficient killing.

Bonardi MA, French RR, Amlot P, Gromo G, Modena D, Glennie MJ. Bonardi MA, et al. Among authors: glennie mj. Cancer Res. 1993 Jul 1;53(13):3015-21. Cancer Res. 1993. PMID: 7686448

9

Delivery of the ribosome-inactivating protein, gelonin, to lymphoma cells via CD22 and CD38 using bispecific antibodies.

French RR, Penney CA, Browning AC, Stirpe F, George AJ, Glennie MJ. French RR, et al. Among authors: glennie mj. Br J Cancer. 1995 May;71(5):986-94. doi: 10.1038/bjc.1995.190. Br J Cancer. 1995. PMID: 7734325 Free PMC article.

10

Mechanisms in removal of tumor by antibody.

Stevenson GT, Bell AJ, Evans TR, French RR, Glennie MJ, Hamblin TJ, Kan KS, Mead GM. Stevenson GT, et al. Among authors: glennie mj. Cell Biophys. 1994;24-25:45-50. doi: 10.1007/BF02789214. Cell Biophys. 1994. PMID: 7736539 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters